Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin, and others. 2006. “Characterization of BRCA1 and BRCA2 mutations in a large United States sample.” Journal of Clinical Oncology, 24, 6, Pp. 863–871.
H.A. Katki. 2006. “Effect of misreported family history on Mendelian mutation prediction models.” Biometrics, 62, 2, Pp. 478–487.
S. Chen, W. Wang, S. Lee, K. Nafa, J. Lee, K. Romans, P. Watson, S.B. Gruber, D. Euhus, K.W. Kinzler, and others. 2006. “Prediction of germline mutations and cancer risk in the Lynch syndrome.” JAMA: the journal of the American Medical Association, 296, 12, Pp. 1479.
Juan R González, Wenyi Wang, Ester Ballana, and Xavier Estivill. 2006. “A recessive mendelian model to predict carrier probabilities of DFNB1 for nonsyndromic deafness.” Human mutation, 27, 11, Pp. 1135–1142.
Sining Chen, Patrice Watson, and Giovanni Parmigiani. 2005. “Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard.” Biostatistics, 6, 3, Pp. 450–464.
Xi Zhou, Edwin S Iversen Jr, and Giovanni Parmigiani. 2005. “Classification of missense mutations of disease genes.” Journal of the American Statistical Association, 100, 469, Pp. 51–60.
Sining Chen, Wenyi Wang, Karl W Broman, Hormuzd A Katki, and Giovanni Parmigiani. 2004. “BayesMendel: an R environment for Mendelian risk prediction.” Statistical applications in genetics and molecular biology, 3, 1, Pp. 1–19.
HA Katki, S Chen, and G Parmigiani. 2004. “Censoring and competing risks in Mendelian mutation prediction models.” Johns Hopkins Univer.
F Marroni, P Aretini, E D?andrea, MA Caligo, L Cortesi, A Viel, E Ricevuto, M Montagna, G Cipollini, S Ferrari, and others. 2004. “Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations.” Journal of medical genetics, 41, 4, Pp. 278–285.
Fabio Marroni, Paolo Aretini, Emma D'Andrea, Maria Adelaide Caligo, Laura Cortesi, Alessandra Viel, Enrico Ricevuto, Marco Montagna, Giovanna Cipollini, Massimo Federico, and others. 2004. “Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations.” European Journal of Human Genetics, 12, 11, Pp. 899–906.
D.A. Berry, E.S. Iversen Jr, D.F. Gudbjartsson, E.H. Hiller, J.E. Garber, B.N. Peshkin, C. Lerman, P. Watson, H.T. Lynch, S.G. Hilsenbeck, and others. 2002. “BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.” Journal of Clinical Oncology, 20, 11, Pp. 2701–2712.
ND Kauff, P Perez-Segura, ME Robson, L Scheuer, B Siegel, A Schluger, B Rapaport, TS Frank, K Nafa, NA Ellis, and others. 2002. “Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families.” Journal of medical genetics, 39, 8, Pp. 611–614.
David M Euhus, Kristin C Smith, Linda Robinson, Amy Stucky, Olufunmilayo I Olopade, Shelly Cummings, Judy E Garber, Anu Chittenden, Gordon B Mills, Paula Rieger, and others. 2002. “Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.” Journal of the National Cancer Institute, 94, 11, Pp. 844–851.
Edwin S Iversen Jr, Giovanni Parmigiani, Donald A Berry, and Joellen M Schildkraut. 2000. “Genetic susceptibility and survival: application to breast cancer.” Journal of the American Statistical Association, 95, 449, Pp. 28–42.
Giovanni Parmigiani, Donald A Berry, Edwin Iversen, Peter Müller, Joellen Schildkraut, and Eric P Winer. 1999. “Modeling risk of breast cancer and decisions about genetic testing.” In Case studies in Bayesian statistics, Pp. 133–203. Springer.
Edwin Iversen, Giovanni Parmigiani, and Donald Berry. 1999. “Validating Bayesian prediction models: a case study in genetic susceptibility to breast cancer.” In Case studies in Bayesian statistics, Pp. 321–338. Springer.
G. Parmigiani, D.A. Berry, and O. Aguilar. 1998. “Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.” The American Journal of Human Genetics, 62, 1, Pp. 145–158.
Elizabeth B Claus, Joellen Schildkraut, Edwin S Iversen Jr, Donald Berry, and Giovanni Parmigiani. 1998. “Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.” Journal of the National Cancer Institute, 90, 23, Pp. 1824–1829.
D.A. Berry, G. Parmigiani, J. Sanchez, J. Schildkraut, and E. Winer. 1997. “Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.” Journal of the National Cancer Institute, 89, 3, Pp. 227–237.